跳至主要内容
临床试验/KCT0002583
KCT0002583招募中未知

Efficacy and safety of FRGP on improving blood glucose and serum cholesterol; A 12week, multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial

BIFIDO0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 75(Year)(—)
性别
All

入选标准

  • 1) Adults aged 20 years old or more and less than 75 years old
  • 2) Fasting glucose = 100 mg/dl and = 125 mg/dl
  • 3) Subject who agrees to participate in the study and signs the informed consent form

排除标准

  • 1) Subjects who had insulin therapy, and/or oral hypoglucosuric agent previously within 3 months before the trial
  • 2) Subjects who took corticosteroid drug previously within 2 months before the trial
  • 3) Subject with uncontrolled hypertension (over 170/100mmHg, when measuring after 10 minutes steady)
  • 4) Subject with TSH =0.1uU/ml or = 10 uU/ml
  • 5) Subject with AST(GOT) or ALT(GPT) or ?-GTP = 3 times the upper limit of normal
  • 6) Inappropriate subject decided by the investigator

研究者

发起方
BIFIDO

相似试验